Clinical trial Recruiting at 4 sites Interventional Ages 18 to 56 Women only

Helping women with Parkinson's disease manage hormonal symptoms

Official title: Enabling Women With Parkinson's Disease to Identify and Better Manage Hormonal Triggers

Run by University Hospital, Grenoble · NCT06582212 · Data updated 2026-11-12

This study is testing whether tracking menstrual cycles and symptoms with a mobile app can help women with Parkinson's disease better manage their hormonal symptoms.

More Parkinson Disease trials

Quick facts

Study typeInterventional
Ages18 Years to 56 Years
SexWomen only
Enrollment100 (estimated)
SponsorUniversity Hospital, Grenoble
Academic / other
Locations4 sites (Grenoble and 3 other locations)
StatusRecruiting
StartedMarch 12, 2025
Main results expectedMarch 12, 2027
Study endsSeptember 12, 2027
Registry record updatedOctober 2, 2026
Trial IDNCT06582212 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are pre-menopausal women aged 18-56 with a diagnosis of Parkinson's disease for at least two years.

Probably not a fit

Patients who are post-menopausal or have conditions that prevent them from completing study procedures may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study aims to explore the relationship between the menstrual cycle and Parkinson's disease symptoms in pre-menopausal women. Participants will use the My Moves Matter mobile application to track their symptoms and hormonal changes over time. The study will assess the reliability of this app in capturing symptom fluctuations and compare subjective data from the app with objective clinical assessments. The goal is to improve management strategies for women experiencing hormonal-related worsening of Parkinson's symptoms.

Why it matters

Potential benefit: If successful, this study could provide women with Parkinson's disease better tools to manage their symptoms related to hormonal changes.

How similar studies have gone: While there is ongoing research into tracking menstrual symptoms in women with Parkinson's disease, this specific approach using the My Moves Matter app is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Non-menopausal women
* Diagnosis of PD according to the MDS criteria onset of PD symptoms since at least two years before inclusion
* Age 18-56 years
* On stable medication regimen for PD for at least two months without foreseen need to modify it within the next three months
* With and without OCP or intrauterine devices (IUD

Exclusion Criteria:

* Post-menopausal women with PD
* Any condition that, in the opinion of the investigator, will preclude the participant from successfully or safely completing study procedures (i.e., dementia, severe depression, etc.)
* People not able to give an informed consent.

Where it's running

  • CHU Grenoble Alpes
    Grenoble, France
    Recruiting
  • CHU Nantes Hôpital Laennec
    Nantes, France
    Recruiting
  • CHU Rennes -Site Pontchaillou
    Rennes, France
    Recruiting
  • Chu Toulouse
    Toulouse, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.